| Accession Number: | 0001104659-23-026088 |
| Date: | 2023-02-23 |
| Issuer: | SUPERNUS PHARMACEUTICALS, INC. (SUPN) |
| Original Submission Date: |
RUBIN JONATHAN
C/O SUPERNUS PHARMACEUTICALS, INC.
9715 KEY WEST AVENUE
ROCKVILLE, MD 20850
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2023-02-23 | 0 | $0.00 | 2,497 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 38.6 | 2023-02-23 | deemed execution date | A | 20,000 (a) | 2033-02-23 | common stock 20,000 | $38.60 | 20,000 | direct | ||
| RESTRICTED STOCK UNITS | 0.0 | 2023-02-23 | deemed execution date | A | 5,000 (a) | common stock 5,000 | $0.00 | 5,000 | direct |
| ID | footnote |
|---|---|
| f1 | the option vests in four equal annual installments beginning on february 23, 2024. |
| f2 | each restricted stock unit represents the right to receive one share of supernus common stock upon vesting. |
| f3 | these restricted stock units will be settled in common stock upon vesting, which will occur in four equal annual installments, beginning on february 23, 2024. |
